- Home
- NBY vs NVVE Comparison
NBY vs NVVE Comparison
Compare NBY & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- NVVE
- Stock Information
- Founded
- NBY 2000
- NVVE 1996
- Country
- NBY United States
- NVVE United States
- Employees
- NBY N/A
- NVVE N/A
- Industry
- NBY
- NVVE Oil Refining/Marketing
- Sector
- NBY
- NVVE Energy
- Exchange
- NBY Nasdaq
- NVVE Nasdaq
- Market Cap
- NBY 2.8M
- NVVE 2.2M
- IPO Year
- NBY 2007
- NVVE N/A
- Fundamental
- Price
- NBY $0.65
- NVVE $2.84
- Analyst Decision
- NBY Strong Buy
- NVVE
- Analyst Count
- NBY 1
- NVVE 0
- Target Price
- NBY $0.85
- NVVE N/A
- AVG Volume (30 Days)
- NBY 502.1K
- NVVE 115.9K
- Earning Date
- NBY 03-25-2025
- NVVE 03-27-2025
- Dividend Yield
- NBY N/A
- NVVE N/A
- EPS Growth
- NBY N/A
- NVVE N/A
- EPS
- NBY N/A
- NVVE N/A
- Revenue
- NBY $13,844,000.00
- NVVE $5,144,831.00
- Revenue This Year
- NBY N/A
- NVVE $200.61
- Revenue Next Year
- NBY $17.31
- NVVE $109.43
- P/E Ratio
- NBY N/A
- NVVE N/A
- Revenue Growth
- NBY 15.40
- NVVE N/A
- 52 Week Low
- NBY $0.36
- NVVE $2.23
- 52 Week High
- NBY $9.10
- NVVE $17.30
- Technical
- Relative Strength Index (RSI)
- NBY 47.50
- NVVE 42.47
- Support Level
- NBY $0.60
- NVVE $2.30
- Resistance Level
- NBY $0.84
- NVVE $2.94
- Average True Range (ATR)
- NBY 0.07
- NVVE 0.43
- MACD
- NBY -0.01
- NVVE -0.02
- Stochastic Oscillator
- NBY 19.04
- NVVE 19.07
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.